The Evolving Algorithm of Biological Selection in Severe Asthma

Allergy: European Journal of Allergy and Clinical Immunology - United Kingdom
doi 10.1111/all.14256
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

Is Evolution by Natural Selection the Algorithm of Biological Evolution?

2012English

Biological Treatment of Severe Asthma: New Objectives and New Treatment Options

Medical Council
2019English

Prevalence of Severe Asthma and Poorly Controlled Severe Asthma During 2009–2013 in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Omalizumab and Mepolizumab in the Landscape of Biological Therapy for Severe Asthma in Children: How to Choose?

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2019English

Pharmacoeconomic Analysis of Using Biological Agents for Uncontrolled Moderate-To-Severe Atopic Asthma in the Russian Federation

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
2020English

Assessing Severe Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2019English

Clinical Issues in Severe Asthma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy